TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 273 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q3 2022. The put-call ratio across all filers is 0.29 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $794,927 | -75.9% | 51,385 | -75.5% | 0.00% | -100.0% |
| Q2 2023 | $3,297,607 | +142.6% | 209,905 | +154.5% | 0.00% | – |
| Q1 2023 | $1,359,039 | -25.0% | 82,466 | -29.0% | 0.00% | -100.0% |
| Q4 2022 | $1,811,972 | +12.7% | 116,152 | -6.3% | 0.00% | 0.0% |
| Q3 2022 | $1,608,000 | +0.2% | 124,004 | +8.5% | 0.00% | 0.0% |
| Q2 2022 | $1,605,000 | +5.3% | 114,301 | +7.4% | 0.00% | 0.0% |
| Q1 2022 | $1,524,000 | -90.4% | 106,400 | -90.8% | 0.00% | -75.0% |
| Q4 2021 | $15,803,000 | +120.0% | 1,159,480 | +164.4% | 0.00% | +100.0% |
| Q3 2021 | $7,182,000 | +1.5% | 438,509 | +4.3% | 0.00% | 0.0% |
| Q2 2021 | $7,073,000 | -10.6% | 420,317 | -3.0% | 0.00% | -33.3% |
| Q1 2021 | $7,913,000 | +332.6% | 433,382 | +331.1% | 0.00% | +200.0% |
| Q4 2020 | $1,829,000 | +22.8% | 100,523 | +20.5% | 0.00% | 0.0% |
| Q3 2020 | $1,489,000 | -4.5% | 83,444 | -4.0% | 0.00% | 0.0% |
| Q2 2020 | $1,559,000 | +42.8% | 86,946 | +20.9% | 0.00% | 0.0% |
| Q1 2020 | $1,092,000 | -22.4% | 71,940 | +0.9% | 0.00% | – |
| Q4 2019 | $1,407,000 | +9.8% | 71,264 | -4.3% | 0.00% | – |
| Q3 2019 | $1,281,000 | -18.0% | 74,502 | -15.7% | 0.00% | -100.0% |
| Q2 2019 | $1,563,000 | -65.9% | 88,350 | -60.7% | 0.00% | -50.0% |
| Q1 2019 | $4,577,000 | -97.3% | 224,717 | -97.8% | 0.00% | -97.4% |
| Q4 2018 | $170,699,000 | – | 10,148,596 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bartlett & Co. LLC | 20,781 | $296 | 0.01% |
| Valued Wealth Advisors LLC | 231 | $3,574 | 0.00% |
| BALDWIN BROTHERS LLC/MA | 2,035 | $29,039 | 0.00% |